Influence of baseline lipids on effectiveness of pravastatin in the CARE trial
作者： Marc A Pfeffer , Frank M Sacks , Lemuel A Moyé , Cara East , Steven Goldman
DOI: 10.1016/S0735-1097(98)00522-1
关键词: Cohort study 、 Medicine 、 Placebo 、 Cardiology 、 Endocrinology 、 Population 、 Internal medicine 、 Cholesterol 、 Cohort 、 Pravastatin 、 Low-density lipoprotein 、 Survival rate
摘要: … pravastatin groups reduced the difference in clinical outcomes at lower LDL cholesterol levels. In both the placebo and pravastatin … as the clinical effectiveness of pravastatin therapy. …
elsevier.com
onlinejacc.org参考文章(28)
Nathan D Wong, Peter WF Wilson, William B Kannel, Serum Cholesterol as a Prognostic Factor after Myocardial Infarction: The Framingham Study Annals of Internal Medicine. ,vol. 115, pp. 687- 693 ,(1991) , 10.7326/0003-4819-115-9-687
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
M. F. Oliver, Doubts about preventing coronary heart disease. BMJ. ,vol. 304, pp. 393- 394 ,(1992) , 10.1136/BMJ.304.6824.393
M Miller, A Seidler, P O Kwiterovich, T A Pearson, Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol. Circulation. ,vol. 86, pp. 1165- 1170 ,(1992) , 10.1161/01.CIR.86.4.1165
Ingar Holme, Cholesterol reduction and its impact on coronary artery disease and total mortality American Journal of Cardiology. ,vol. 76, pp. 10- ,(1995) , 10.1016/S0002-9149(99)80465-2
Juha Pekkanen, Shai Linn, Gerardo Heiss, Chirayath M. Suchindran, Arthur Leon, Basil M. Rifkind, Herman A. Tyroler, Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease New England Journal of Medicine. ,vol. 322, pp. 1700- 1707 ,(1990) , 10.1056/NEJM199006143222403
Jeremiah Stamler, Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded? JAMA. ,vol. 256, pp. 2823- 2828 ,(1986) , 10.1001/JAMA.1986.03380200061022
William P. Castelli, Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels JAMA. ,vol. 256, pp. 2835- 2838 ,(1986) , 10.1001/JAMA.1986.03380200073024
G Davey Smith, Juha Pekkanen, None, Should there be a moratorium on the use of cholesterol lowering drugs BMJ. ,vol. 304, pp. 431- 434 ,(1992) , 10.1136/BMJ.304.6824.431